Register for the Gastrointestinal Cancers Symposium and join us for three days of translational research, novel clinical therapies, and state-of-the-art science in GI oncology.
The Gastrointestinal Cancers Symposium is a high-profile, specialized oncology event designed for the exchange of the latest research and science in cancers of the pancreas, small bowel, and hepatobiliary tract; colon and rectum; and esophagus and stomach.
Multidisciplinary in content and scope, the meeting brings together a diverse group of stakeholders involved in the prevention, detection, and treatment of GI cancers. The meeting’s intimate and interactive setting facilitates a forum for networking and discussion to exchange ideas, best practices, and science that will lead to future progress.
The exhibits at the Gastrointestinal Cancers Symposium highlight the most advanced treatments, products, and services in oncology and provide attendees the opportunity to meet with representatives from the healthcare industry, including pharmaceutical companies and advocacy groups.
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization that represents physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO’s efforts also are directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. ASCO has more than 35,000 members worldwide, with international members from more than 100 countries. The Society is led by President Clifford A. Hudis, MD, of Memorial Sloan Kettering Cancer Center, and CEO Allen S. Lichter, MD.